Shibata H, Kohno S, Ohata K
Central Research Laboratory, Kotaro Pharmaceutical Co., Ltd.
Arerugi. 1995 Oct;44(10):1234-40.
Effects of oral administration of MBST on 48 hr homologous passive cutaneous anaphylaxis (PCA) and allergic rhinitis in rats were examined. Administration of MBST (1,000 mg/kg/day) for 5 consecutive days with the final dosing at 1 day before antigen challenge did not effect on PCA. However, the reaction was significantly inhibited when the drug (1,000 mg/kg) was singly given 1 hr before antigen challenge. The drug (1,000 mg/kg, 1 hr prior to antigen challenge) tended to reduce the dye leakage into nasal cavities by antigen, while it did not affect on the anaphylactic histamine release into the cavities. The component of the chinese plants in the formula inhibiting the dye leakage was found to be Mao. However, l-ephedrine and d-pseudoephedrine, which are contained in Mao in a large amount, did not contribute to the inhibiting effect on dye leakage. These results suggest that MBST may be therapeutically effective for atopic disease including rhinitis, through the mechanism other than the inhibition of histamine release.
研究了口服MBST对大鼠48小时同源被动皮肤过敏反应(PCA)和过敏性鼻炎的影响。连续5天给予MBST(1000毫克/千克/天),最后一次给药在抗原攻击前1天,对PCA没有影响。然而,当在抗原攻击前1小时单次给予该药物(1000毫克/千克)时,反应受到显著抑制。该药物(1000毫克/千克,在抗原攻击前1小时)倾向于减少抗原引起的染料渗漏到鼻腔中,而对鼻腔中过敏组胺的释放没有影响。发现配方中抑制染料渗漏的中药成分是麻黄。然而,麻黄中大量含有的l-麻黄碱和d-伪麻黄碱对染料渗漏的抑制作用没有贡献。这些结果表明,MBST可能通过抑制组胺释放以外的机制对包括鼻炎在内的特应性疾病具有治疗效果。